Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Where there's a will, there's a way. And Pfizer appears to have the will to stake a claim in the massive obesity drug market.
Source: fool.com
Stay updated with breaking news from Albert Bourla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Where there's a will, there's a way. And Pfizer appears to have the will to stake a claim in the massive obesity drug market.
PFE earnings call for the period ending March 31, 2024.
The company's revenues for the quarter totalled $14.9bn, a 20% decrease from the same quarter of the previous year.
Find out why Albert Bourla is on the TIME100 Health list.